Bone Graft Substitutes

BGS Basics - Beyond Bone

• Why BGS? To overcome limitations of:
  • Autografts: Donor site morbidity, limited quantity.
  • Allografts: Disease transmission risk, immunogenicity, slower incorporation.
• Ideal BGS Properties:
  • Osteoconductive (scaffold for bone ingrowth)
  • Osteoinductive (stimulates differentiation of MSCs into osteoblasts)
  • Osteogenic (contains viable osteoprogenitor cells - rare for substitutes)
  • Biocompatible & Bioresorbable
  • Structural integrity
  • Readily available, sterile, cost-effective.
• Bone Healing Triad (📌 "Cells, Signals, Scaffold"):
  • Osteogenic cells
  • Osteoinductive signals (e.g., growth factors like BMPs)
  • Osteoconductive matrix/scaffold

⭐ Most bone graft substitutes primarily provide osteoconduction; some also offer osteoinduction. True osteogenesis is typically absent. oka

BGS Spectrum - Classify & Conquer

• By Biological Activity (The "O"s):
  • Osteoconductive: Provides scaffold for bone ingrowth (e.g., ceramics, collagen).
  • Osteoinductive: Induces new bone formation via cell differentiation (e.g., BMPs, DBM).
  • Osteogenic: Contains living bone-forming cells (e.g., autograft, bone marrow aspirate).
  • Osteopromotive: Enhances overall bone healing environment (e.g., PRP).
• By Material Source/Type:
  • Allografts: Human cadaveric source (e.g., DBM - osteoinductive & osteoconductive).
  • Xenografts: Animal origin (e.g., bovine, porcine - primarily osteoconductive).
  • Synthetic: Lab-derived.
    • Ceramics: Calcium phosphates (HA, TCP), bioactive glasses.
    • Polymers: PLA, PGA.
    • Composites: Ceramic-polymer blends.

⭐ Demineralized Bone Matrix (DBM) is a versatile allograft, being both osteoconductive and osteoinductive due to preserved growth factors.

Material Marvels 1 - Ceramics & DBM

• Ceramics: Synthetic, inorganic, crystalline materials.

  • Calcium Phosphate (CaP): Osteoconductive, resorbable at varying rates.

    • Hydroxyapatite (HA): $Ca_{10}(PO_4)_6(OH)_2$. Slowest resorption, good structural integrity.
    • Tricalcium Phosphate (TCP): $Ca_3(PO_4)_2$. Faster resorption than HA.
    • Biphasic CaP (BCP): HA+TCP mix; combines stability & resorption.

  • Calcium Sulphate (Plaster of Paris):

    • Rapid resorption (4-12 weeks); osteoconductive.
    • Use: Bone void filler. ⚠️ Can cause transient serous drainage.

  • Bioactive Glass (e.g., Bioglass 45S5):

    • Bonds directly to bone; osteoconductive & osteostimulative (releases $Si^{4+}$, $Ca^{2+}$, $PO_4^{3-}$ ions).
• Demineralized Bone Matrix (DBM):
  • Acid-extracted allograft; preserves collagen matrix & growth factors (BMPs).
  • Osteoconductive; osteoinductive (variable, BMP-dependent).
  • Forms: Putty, gel, strips, powder. Carrier often used for handling.
  • Not for primary structural support alone.

  ⭐ DBM's osteoinductive potential is primarily due to Bone Morphogenetic Proteins (BMPs) preserved in its demineralized matrix.

Material Marvels 2 - Growth Factors & Synthetics

• Growth Factors (Osteoinductive)
  • Bone Morphogenetic Proteins (BMPs)
    • rhBMP-2, rhBMP-7 (OP-1)
    • Mechanism: MSCs → osteoblasts
    • Carrier needed (collagen)
    • Uses: Nonunions, spinal fusion
    • ⚠️ Risks: Swelling (BMP-2 cervical), seroma, ectopic bone
• Synthetic Bone Graft Substitutes (Mainly Osteoconductive)
  • Calcium Phosphates (CaP)
    • Hydroxyapatite (HA): Slow resorption, strong
    • β-Tricalcium Phosphate (β-TCP): Faster resorption
    • Biphasic CaP (BCP): HA + β-TCP; balanced properties
  • Calcium Sulfate (Plaster of Paris)
    • Rapid resorption; exothermic
    • Use: Void filler
  • Bioactive Glass (e.g., Bioglass®)
    • Osteostimulative; bonds bone
    • Forms HCA layer

⭐ rhBMP-2 (Infuse®) and rhBMP-7 (OP-1®) are FDA-approved osteoinductive proteins; rhBMP-2 is linked to ↑ early post-op swelling, especially in anterior cervical spine.

High‑Yield Points - ⚡ Biggest Takeaways

• DBM: Offers osteoconduction and osteoinduction (BMP-dependent, variable potency).
• BMPs (rhBMP-2, rhBMP-7): Powerful osteoinductive agents; risks include seroma, ectopic bone formation.
• Hydroxyapatite (HA): Osteoconductive, slow resorption, provides lasting structural scaffold.
• β-Tricalcium Phosphate (β-TCP): Osteoconductive, faster resorption than HA, allows earlier bone replacement.
• Calcium Sulphate: Rapidly resorbed (over weeks), acts as a temporary void filler.
• Most substitutes are osteoconductive; few are osteoinductive; none are truly osteogenic like autograft.